AI Health Technology Limited

As of December 31, 2025, AI Health Technology Limited carries a market capitalization of 175.09M, placing it among publicly traded companies globally. Its enterprise value stands at 197.33M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, AI Health Technology Limited has 360.76M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, AI Health Technology Limited maintains a current ratio of 1.51, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, AI Health Technology Limited's stock has declined approximately 14.44% over the past 52 weeks. The 50-day moving average sits at 0.42, while the 200-day moving average is 0.47.

As of December 31, 2025, AI Health Technology Limited holds 30.13M in cash and equivalents against 51.41M in total debt, resulting in a net debt position of 21.28M. Total book value stands at 65.44M, with working capital of 47.09M providing operational flexibility.

AI Health Technology Limited's most recent stock split took place on May 6, 2025 with a 7:8 split ratio.